Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc.（HARP）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
harp · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2024年8月9日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$700
Consensus
$700
+2942.2% upside
Low
$700
Median: $700 · Last Close: $23.01
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $23.03 | ↑ 0.08% |
1-day model range: $23.01–$23.04. Peak: $23.04 (+0.08%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HARP · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-04-03 | Canaccord Genuity | Maintains | Buy→Buy |
| 2023-03-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-12-14 | Truist Securities | Downgrade ↓ | Buy→Hold |
| 2022-11-15 | Baird | Downgrade ↓ | Outperform→Neutral |
| 2022-11-15 | SVB Leerink | Maintains | Outperform→Outperform |
| 2022-08-29 | Citigroup | Maintains | Buy→Buy |
| 2022-08-23 | Truist Securities | Maintains | Buy→Buy |
| 2022-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-08-11 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Harpoon Therapeutics, Inc. (HARP) stock. Of the recent 29 rating actions, 2 were upgrades and 4 were downgrades. 9 analysts currently cover HARP.
分析师推荐趋势
HARP analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 5 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$38M
↑ 102.2% YoY
Revenue Next Year
$56M
↑ 45.9% YoY
EPS This Year
$-2.00
EPS Next Year
$-4.56
↑ 128.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast HARP EPS of $-2.00 for the current fiscal year, based on estimates from 8 analysts. The HARP revenue forecast is $38M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
HARP 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。HARP 的共识目标价为 $700.00（+2942.2% 上行空间），分析师共识为 Buy。
HARP 的短期预测（明日）为 $23.03（+0.08%）。
Harpoon Therapeutics, Inc. 在 NASDAQ 上市，代码 HARP。HARP 在 2027 年的整体展望偏积极，在覆盖分析师中约 78% 对应 Buy 共识。
常见问题
HARP 预测 · 8 个问题根据 9 位华尔街分析师，HARP 的 12 个月平均目标价为 $700.00，最高 $700.00、最低 $700.00。若有图表，中位目标价可在上方查看。相对当前价 $23.01，隐含约 +2942.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.